Table 3.
Non-compartmental analysis of plasma data for PTX in rats after i.v. administration of HA-SS-ATRA21/PTX, HA-ATRA20/PTX and Taxol® (mean ± SD, n = 5).
| Pharmacokinetic parameters | HA-SS-ATRA21/PTX | HA-ATRA20/PTX | Taxol® |
|---|---|---|---|
| AUC0−t (h.µg/ml) | 36.86 ± 5.64** | 34.07 ± 1.29** | 4.02 ± 0.06 |
| T1/2 (h) | 69.11 ± 24.30 | 108.44 ± 73.95 | 8.49 ± 1.32 |
| MRT (h) | 20.95 ± 1.29** | 21.86 ± 0.46** | 3.21 ± 0.02 |
| CL (ml/h/kg) | 55.84 ± 30.80** | 35.59 ± 13.64** | 649.48 ± 31.50 |
| Vd (ml/kg) | 5250.93 ± 112.98 | 6278.07 ± 656.18 | 7910.78 ± 886.69 |
P < 0.01 versus Taxol.